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translations based on analysis of qualitative data collected during pilot-testing. 
In an effort to create a universal Spanish version, linguists from various Spanish-
speaking countries were recruited to achieve a translation that could be used in 
all regions in which Spanish is spoken. Results: After the translation phase was 
completed, psychometric testing was carried out. 485 adult items and 139 pediatric 
items from 11 subdomains were tested with native Spanish speakers (2,500 adults 
and 1,200 children) from an online general population panel. Different item banks 
exhibited various levels of differential item functioning (DIF) across Spanish and 
English speaking populations. In order to retain all items in each bank, a hybrid 
approach was used in which English calibration metrics were used for non-DIF 
items and Spanish calibrations were used for items exhibiting DIF. ConClusions: 
Spanish Computer Adaptive Tests (CATs) for Anxiety, Depression, Fatigue, Physical 
Function and Sleep Disturbance are currently available in Assessment Center (www.
assessmentcenter.net).
PIH17
PrelImInary results QualIty of lIfe, PHysIcal actIvIty, and 
sedentary BeHavIor In college students
Mendoza F.J., Parra G., Bastardo Y.M.
Universidad Central de Venezuela, Caracas, Venezuela
objeCtives: Being physically active is associated with reduced risk of chronic 
diseases. In this study we examined the associations of physical activity and 
sedentary behavior with perceived quality of life (QoL) in college students in 
Venezuela. Methods: A convenience sample of 64 students at Central University 
of Venezuela, ranging in age from 17 to 43 years was surveyed using a written 
questionnaire. Quality of life was measured using a single-item from the Health 
Survey Short-Form 36 (SF-36), EuroQol health states descriptive system (EQ-5D), 
and a visual analogue scale (EQ-VAS). The relationships between health status, 
physical activity, and sedentary behavior were estimated computing Kendall’s τ 
correlation coefficients. Statistic analysis was performed by SPSS 13.0. Results: 
The sample consisted of 41 females and 22 males. The sample had a mean age of 
20.54 years (s.d. 3.99 years). Two subjects (3.2%) reported some problems with mobil-
ity. Three subjects (4.8%) reported some problems with usual activity. Ten subjects 
(15.9%) reported some problems with pain. One subject (1.6%) reported extreme 
problems and 10 reported some problems with anxiety. Three subjects (4.8%) rated 
health status of fair or poor. Subjects reported doing vigorous physical activities on 
a mean of 2.05 days during the past week. Subjects reported walking for a mean of 
93.49 minutes during the past week. Subjects reported spending a mean of 301.31 
minutes sitting during the past week. Neither physical activity nor sedentary behav-
ior was associated with quality of life in our population. ConClusions: Study 
limitations include the sample size and the use of a convenient sample. Overall, 
this exploratory study demonstrates that the quality of life of college students in 
Venezuela was good.
IndIvIdual’s HealtH – Health care use & Policy studies
PIH18
comPared analysIs of IneQualItIes In HealtH and Influence of 
socIal determInants of HealtH In cuBa and usa
Diaz de León-Castañeda C.1, Ramírez-Fernández D.M.2, Pinzon Florez C.E.1
1Instituto Nacional de Salud Pública, Cuernavaca, Mexico, 2National Institute of Public Health, 
Cuernavaca, Mexico
objeCtives: Equity is a desirable goal for health systems performance and the 
comparison of them is important to learn lessons from the best. In the present study 
our goal was to analyze comparatively inequalities in health and the influence of 
social determinants of health in two countries with different social, economical 
and political contexts: Cuba and USA. Methods: A compared inequalities analy-
sis was made in three health indicators related with the performance of health 
systems: maternal mortality rate (MMR), infant mortality rate (IMR) and life expec-
tancy at birth (LEB) using published geopolitical unities information from USA 
and Cuba in 2008 and through the computation of inequality indexes suggested 
in literature and statistical analysis. Also there were comparatively analyzed the 
effects on these health indicators of three proxy indicators of social determinants 
of health (PISDH’s): percent of rural population (PRP), percent of non white popula-
tion (PNW) and physicians rate (PHR), through the computation of effect indexes 
for significantly Pearson correlations. Results: Cuba showed significantly higher 
inequality than USA in MMR; USA showed higher inequality in LEB; the inequality 
in IMR was statistically not different. The PRP was a risk factor for the LEB in USA 
but a protector factor in Cuba; PNW was a risk factor for MMR and IMR in USA only, 
although with low effect index; PHR was a risk factor for MMR in USA only, perhaps 
by his correlation with another PISDH’s. ConClusions: Important inequalities 
were identified in both countries. The PISDH’s analyzed affected health indica-
tors principally in USA. Another economic PISDH’s are required for more detailed 
comparative analysis in the effects of PISDH’s in health inequalities. There are few 
comparative analysis of health systems in the literature that employ quantitative 
methodology as used in this study.
PIH19
atencIón Intercultural del Parto vagInal en méxIco: costos 
económIcos, determInantes y retos de la ImPlementacIón de 
PolítIcas efectIvas en BenefIcIo de las mujeres Indígenas
Heredia I.1, Meneses S.1, Montag D.2, Ibañez M.1, Hernández E.1, González Block M.A.1
1Instituto Nacional de Salud Pública, Cuernavaca, Mexico, 2School of Social and Cultural 
Anthropology, Oxford, UK
objeCtivos: Estimar los costos de atención del parto vaginal en unidades del 
sector público de salud de Oaxaca y Chiapas, para dos modelos asistenciales 
alternativos (convencional e intercultural), durante 2008-2012 e identificar los 
principales determinantes de la implementación efectiva y puesta a escala de 
modelos interculturales de atención materna en beneficio de la población indí-
23.5%), and pharmacy records (n= 7, 8.6%). Different versions of the Morisky test 
were identified (modified, 4-item, and 8-item). Other validated adherence ques-
tionnaires identified within the studies (with more than one occurence) were: 
MAT (n= 3) and MedTake (n= 2). Pill counting, medical chart review, and serum drug 
determination were used in 4 studies each. None study used electronic monitoring 
of adherence. ConClusions: Data from the available Brazilian studies indicate a 
variety of methods adopted by local researchers for measuring adherence to treat-
ment. Indirect measures are more common, particularly those based on patients’ 
or caregivers’ perception of adherence behaviors. Most studies enrolled HIV/AIDS 
or hypertension patients. Other chronic conditions with long term continuous oral 
therapies were underrepresented.
PIH13
Prometex - Promevoz, tool suPPort of PHarmaceutIcal care for tHe 
scoPe of ProPer adHesIon In colomBIa, 2009-2012
Estrada J.I.1, Serna J.A.2, Toro C.M.3, Rios J.4, Sanchez L.3, Suarez J.E.1
1CES University, Medellin, Colombia, 2EAFIT University, Medellin, Colombia, 3Antioquia 
University, Medellin, Colombia, 4Granada University, Medellin, Colombia
objeCtives: To determine if the tool Prometex – Promevoz, helps in reducing the 
drug therapy use problems identified in the Pharmacotherapy Monitoring for 
pharmaceutics. Methods: Prometex – Promevozis a tool for telephony (voice 
and text messages) you want, combined with other strategies, to maintain and 
increase drug compliance, remembering the exact times of taking medication. 
With prior consent, information is sent to all medications they are prescribed, 
coded for strictly personal interpretation and handling of confidential and bidi-
rectional. A descriptive longitudinal, which includes users with at least two visits 
to Pharmacotherapy Monitoring, a pre and post-deployment of telephony tool. 
Demographic variables are analyzed and compared in an exploratory way in the 
same population type and amount of drug therapy use problems at the begin-
ning and end of use of the tool. Results: A total of 25.6% of patients had at least 
1 drug therapy use problems during the first consultation of Pharmacotherapy 
Monitoring, a situation that changed after the use of Prometex – Promevoz, which 
decreased the proportion of patients with drug therapy use problems to 16.7%. 
A decrease between the two observations of 53.3% with a chi squeare (ji2) of 9,56 
and a p value of 0,002. ConClusions: The tool Prometex – Promevoz appears 
to contribute to the decline in drug therapy use problemsidentified in the 
Pharmacotherapy Monitoring.
PIH14
PatIent-rePorted outcomes: are tHey WortH It? an examInatIon In 
Pro value tHrougH case studIes
DeMuro C.1, Gnanasakthy A.2
1RTI Health Solutions, Research Triangle Park, NC, USA, 2Novartis Pharmaceuticals, East Hanover, 
NJ, USA
objeCtives: Increasing competition, pressure from payers and greater regulatory 
constraints require pharmaceutical manufacturers to seek methods for product 
differentiation. One way of differentiating pharmaceuticals is the generation of 
patient-centric value messages utilizing patient-reported outcomes (PROs). PROs 
may be primary or nonprimary endpoints in clinical trials, and commercial use is 
typically dependent on PROs that support key endpoints and appear in labeling 
(US) or in the summary of product characteristics (EU) to support reimbursement. 
However, despite this obvious utility, the cost and logistical complexity of including 
PROs may deter clinical teams. The purpose of this research is to better understand 
the value of PROs and the ability of PROs to provide data critical to decision making 
for patients, clinicians, and payers. Methods: A detailed case study was conducted 
of three marketed products: ivacaftor, mirabegron, and botulinum type A. Selection 
of these products represent a range of therapeutic areas and may provide insight 
into the differing roles of PROs. For each product available US and European sub-
mission and review documents were analyzed. Results: PROs were included in 
all three submissions. A PRO labeling claim was granted for a primary endpoint for 
mirabegron, and while claims for nonprimary PROs were denied, the review docu-
ments indicate that the decision for drug approval was supported by results of the 
nonprimary endpoints. Ivacaftor was granted a claim based on a nonprimary PRO 
endpoint, though the tool did not meet the specifications of the FDA’s PRO guidance. 
Finally, health authorities recognized the impact on health-related quality of life for 
botulinum type A for migraine in support of a positive appraisal. ConClusions: 
The results of this review indicate that PROs included in clinical trials may have a 
strong influence on the drug approval process, regardless of whether a PRO labeling 
claim is ultimately granted. Further research is warranted.
PIH15
tHe PatIent-rePorted outcomes measurement InformatIon system 
In sPanIsH
Arnold B.J.1, Correia H.2, Pérez B.1, Lent L.1, Cella D.2
1FACITtrans, Elmhurst, IL, USA, 2Northwestern University, Chicago, IL, USA
objeCtives: The Patient-Reported Outcomes Measurement Information System 
(PROMIS®) provides accurate and efficient measurement of patient-reported out-
comes. Developed in English using qualitative methods, PROMIS tools measure 
symptoms, such as pain and fatigue, and aspects of health-related quality of life 
across a wide variety of chronic diseases and conditions. Methods: To enable 
participation of Spanish-speaking populations the PROMIS banks were translated 
into Spanish using methods that would ensure linguistic equivalence and cultural 
appropriateness. The Spanish translation of 825 adult and 156 pediatric items was 
obtained through the FACIT Multilingual Translation Methodology which consists 
of the following ten steps: 1) creation of item definitions; 2) two simultaneous for-
ward translations; 3) reconciliation of forward translations; 4) back-translation of 
reconciliation; 5) expert review of back-translation and previous steps; 6) prelimi-
nary finalization for pilot-testing; 7) cross-cultural harmonization; 8) quality assur-
ance; 9) cognitive testing with native speakers of Spanish; and 10) finalization of 
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PIn3
Burden of varIcella In latIn amerIca: a systematIc revIeW and 
crItIcal analysIs
Yang H.K.1, Liaw K.L.2, Manoff S.2, Kuter B.1
1Merck & Co, Inc., West Point, PA, USA, 2Merck & Co, Inc., Upper Gwynedd, PA, USA
objeCtives: Varicella is a common, vaccine-preventable illness with significant 
public health impact in Latin America (LA). This study aimed to review the epi-
demiology and economic burden of varicella, and to perform a critical analysis 
of available data in LA. Methods: A comprehensive literature review was con-
ducted in major databases and government websites to identify published data on 
epidemiology and economic burden of varicella in LA. Study data were extracted 
systematically including incidence rates, lifetime prevalence, mortality, type and 
rates of complications, as well as use of health care resources (hospitalizations, phy-
sician office visits, others) and both direct and indirect costs associated with vari-
cella. Critical analyses of study quality and data availability are performed for each 
country. Results: Published studies were identified from ten countries including 
Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Mexico, Paraguay, Uruguay, and 
Venezuela. Annual incidence rates ranged from 20 per 100,000 in Uruguay up to 
381 per 100,000 in Mexico. Incidence was highest among children < 10 years of age, 
bearing increased utilization of healt health care resources. Bimodal seasonal pat-
terns of varicella were reported in Argentina, Mexico and Uruguay. Most frequent 
complications among hospitalized patients were skin and soft tissue infections, 
respiratory infections and neurological complications. Patients hospitalized for 
varicella stayed generally between 1-5 days. Critical analysis suggested that most 
published studies had limitations including data representativeness and study 
design issues. Data gaps in the epidemiology and economic burden of varicella 
were also found on the country level. ConClusions: Currently there is limited 
information available on burden of varicella in Latin America, potentially due to 
the lack of mandatory reporting and active surveillance systems for varicella in the 
region. Country-specific epidemiological information and varicella-related health 
care resource utilization data are needed to elucidate the disease burden for devel-
oping appropriate immunization recommendations and informing decision makers 
about the value of varicella vaccination.
InfectIon – cost studies
PIn4
costs and outcomes assocIated WItH multIdrug resIstant 
staPHylococcus aureus BacteremIa
Singh S.1, Tiwari P.2
1National Institute of Pharm. Edu & Res (NIPER), S.A.S. NAGAR, Punjab, India, 2National Institute 
of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, India
objeCtives: There is a dearth of studies in India that quantifies the impact of mul-
tidrug resistance on key economic and clinical outcomes. The aim of this retrospec-
tive cohort study was to determine the costs of treatment and evaluate the clinical 
outcomes in patients suffering from multidrug resistant (MDR) Staphylococcus aureus 
bacteremia and compare these with the costs and clinical outcomes of patients 
suffering from non-MDR S. aureusbacteremia. Methods: Data was collected from 
2007 through October 2010 from a private tertiary care hospital in India. Multidrug 
resistance was defined as resistance to ≥ 3 classes of antimicrobial drugs. Resistance 
within a class was defined as resistance to ≥ 1 antimicrobial agent. Results: A 
total of 42 cases were included in the study of which 19 belonged to the MDR cohort 
and 23 to the non-MDR cohort The total mean cost for treating patients in the 
MDR cohort was 1.35 times higher compared to the non-MDR cohort (INR 230,000 
[170,000-623,000] versus INR 171,000 [91,000-310,000]; P = 0.049). Death was reported 
in similar number of patients in both the groups (5 patients and 4 patients in the 
MDR cohort and non-MDR cohort, respectively). The number of deaths attribut-
able to sepsis was also similar between the groups (16% vs. 13%). The total mean 
length of stay in hospital was significantly longer for the MDR cohort compared 
with non-MDR cohort (19 days [16-28] vs. 14 days [9.2-18.5]; P = .024). However, 
after the onset of bacteremia, the difference in the length of stay between the 
groups was not statistically significant (16 days [14-21] vs. 11 days [8-15.5]; P = 
0.12). ConClusions: Multidrug resistance in S. aureus bacteremia was associated 
with a significant increase in hospital costs.
PIn5
costos económIcos asocIados a secuelas de menIngItIs en colomBIa
Alvis-Guzmán N.1, Coronell-Rodriguez W.1, Castañeda-Orjuela C.A.2, De la Hoz-Restrepo F.2
1Universidad de Cartagena, Cartagena de Indias, Colombia, 2Universidad Nacional de Colombia, 
Bogotá, Colombia
objeCtivos: Estimar los costos económicos asociados al tratamiento de secuelas 
de meningitis en una serie de casos en Colombia. MetodologíAs: De la base de 
datos de 253 pacientes atendidos entre 2009 y 2012 en una institución de rehabili-
tación ubicada en Cartagena de indias Colombia, se identificaron 37 diagnóstico de 
meningitis bacteriana y entre estos se confirmaron 19 casos de secuelas. De estos, 
se microcostearon 13 pacientes con secuelas asociadas a un episodio de meningitis 
meningocócica verificada por pruebas de laboratorio. Las perspectivas del costeo 
fueron del sistema de salud y la sociedad. En la primerara se consideraron todos 
los costos médicos directos originados durante el primer año de tratamiento de la 
secuela y en los años subsiguientes. En la perspectiva social, adicionalmente se 
consideraron la compra de órtesis y prótesis, adecuaciones del hogar, gastos de 
transporte y perdida de de productividad, cuando el cuidador tuvo que abandonar el 
trabajo para asistir al paciente. Los costos se expresaron en US dólares de 2012 (Tasa 
de cambio 31 dic 2012 1 USD por COP$ 1768.23). ResultAdos: De los 13 pacientes 
considerados, 5 tenían secuelas de retardo psicomotor, cuatro de hipoacusia neuro-
sensorial, tres de epilepsia y un trastorno del comportamiento. Desde la perspectiva 
del sistema de salud, los costos directos de tratamiento para el primer año y cada 
año subsiguiente fueron US$ 3,106.27 (IC95%: 454.5 – 5,758.0) y US$ 496.1 (IC95%: 
449.2 - 509.3); desde la perspectiva social fueron US$ 4,647.1 (IC95%: 4,183.8 – 5,082.3) 
gena. MetodologíAs: Análisis transversal con información de expedientes 
clínicos de 488 usuarias de los servicios estatales de salud. Se realizó un micro-
costeo y se estimaron los costos de la utilización de recursos, desde la perspectiva 
del sector salud. Se realizaron pruebas estadísticas tipo X2 de Pearson y prueba t 
para identificar diferencias en las variables de estudio. Los costos se expresan en 
pesos mexicanos del 2012. Se realizaron entrevistas semi-estructuradas a usuarias 
y actores de niveles estratégicos, tácticos y operativos involucrados en el diseño 
e implementación de modelos interculturales en salud materna en ambos esta-
dos. ResultAdos: El 66% de las mujeres eran indígenas. 80% de los costos se con-
centraron en consultas y hospitalización. El costo promedio por este concepto fue 
de $4188 (modelo convencional) y $4002 (modelo intercultural). Se identificaron dos 
principales modelos interculturales: el parto vertical y la vinculación entre parteras 
tradicionales y prestadores de servicios. Existen divergencias entre las expectativas 
de las usuarias y sus familiares y los actores involucrados en el diseño e implemen-
tación de las intervenciones interculturales y escasa conciencia entre prestadores 
de servicios y tomadores de decisiones sobre la complejidad del significado de la 
atención intercultural en salud materna. ConClusiones: Incorporar elementos 
interculturales en la atención al parto vaginal, no añade costos adicionales al sec-
tor salud, mientras sí puede asociarse con mayor aceptación de las usuarias. Se 
requiere una mayor coordinación entre los actores, para la implementación efectiva 
de intervenciones interculturales, en apoyo a las estrategias de reducción de la 
mortalidad materna.
InfectIon – clinical outcomes studies
PIn1
dynamIc modelIng of vector-Borne dIseases (vBd): tHe examPle of 
malarIa
Snedecor S.J.
Pharmerit International, Bethesda, MD, USA
bACkgRound: VBD, such as Chagas disease, dengue, or malaria, are transmitted 
from to humans by insects or other organisms and can be difficult to control. VBD 
transmission involves a combination of interactions among multiple factors includ-
ing animal hosts, vectors, and humans. Dynamic modeling methodologies used 
to describe infectious disease transmission processes are amenable to a situation 
when infection and interaction of ≥ 1 species, as is the case of VBD. This work dem-
onstrates the use of such methodology for the example of malaria. Methods: A 
dynamic, compartmental model was developed to simulate malarial disease trans-
mission among the human and mosquito populations. The model consists of a mos-
quito population divided into susceptible, exposed but not infectious, and infectious 
and a human population including susceptible, exposed but not infectious, infec-
tious but immune and infectious susceptible individuals. Parameters include human 
and mosquito birth rates and life expectancies, probabilities of disease transmis-
sion between humans and mosquitoes, and number of mosquito blood meals per 
day. The effect of anti-malarial treatment was modeled to assess epidemiologic 
outcomes under various scenarios. The model was solved analytically to determine 
the expected number of cases per person per year under each scenario. Results: 
When transmission intensity is low, treatment of infected individuals with a therapy 
providing a subsequent 15-day period of immunity reduces the incidence of disease 
from 0.481 with no treatment to 0.475 cases per person per year (pppy). In moderate 
and very high transmission settings the incidence of disease is reduced from 2.385 
to 2.171 cases pppy and 9.899 to 7.007 cases pppy, respectively. ConClusions: This 
model demonstrates the utility of dynamic modeling methodology to examine the 
spread of VBD. Several model parameters may be varied to assess the epidemiologic 
impact of a number of treatments and vector control mechanisms. These models 
may be expanded for cost-effectiveness analysis.
PIn2
alternatIve HIgH level dIsInfectants to ProcessIng flexIBle 
endoscoPes
Passeri L.A., Psaltikidis E.M., Leichsenring M.L., Nakamura M.H.Y., Burstoff J.M.
Unicamp, Campinas, Brazil
objeCtives: Endoscopy is fundamental in different medical specialties, with 
increasing use. Endoscopes are expensive equipment, complex, thermo sensi-
tive, delicate materials and submitted to high-level disinfection (HLD). The most 
commonly used disinfectant is glutaraldehyde (GLU) due to its high compatibility 
with the materials and low cost. However, evidence of toxicity to professionals 
and the identification of mycobacteria tolerant to GLU caused changes in Brazilian 
legislation on the issue, pressing health services to search for alternative desin-
fectants. Search for evidence on the effectiveness, toxicity and potential damage 
to endoscopes by alternative disinfectants to GLU available in the Brazilian mar-
ket. Methods: The study sample was semi-critical endoscopes flexible (digestive, 
respiratory and cystoscope), the intervention was HLD with peracetic acid (PA), 
Ortho-Phthalaldehyde (OP) and Electrolyzed Acid Water (EAW), compared to GLU, 
with outcomes HLD effectiveness, toxicity and damage to equipment. Results: 
Were identified 822 publications (2008-2013) on 13 databases, 23 studies were 
selected considering the best quality of available evidence. As for effectiveness, 
the findings draw attention to the intrinsic resistance of subclass Coccidia spp to 
all evaluated disinfectants and acquired tolerance by GLU strain of Mycobacterium 
massilienses which caused an outbreak of infection with more than 2000 cases 
in Brazil. About toxicity, the most frequently reported adverse events are coli-
tis (no definitive causal relationship with the germicide used) and anaphylactic 
reactions by OP in cystoscopy. There is lack of published data on damage caused 
in endoscopes by the disinfectants; the few studies on the theme indicate the 
importance of adequate handling of equipment for conservation of its functional-
ity. ConClusions: The publications show superiority of the PA and OP for effi-
cacy in HLD. Only the OP clearly had adverse event related to their use. There is 
insufficient evidence in literature to assert the inferiority of some disinfectant 
for damage to equipment.
